Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MICS 8.08 those low floats can gold bar at right temperature.
ISPO 4.77 will wealthy people give up vacations?
MICS 7.49 waiting for $10 to buy, confirming last free thing to use once you buy it except for the electricity!
DTIL 1.31 went to blood bank to buy more.
DTIL: Note well
DTIL is no brainer, second after MICS alert a couple of weeks ago, and second after never finding a true live present one I was comfortable to declare.:
See this post which confirms:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169114174
DTIL: 1.28 no brainer, thread of subtext starts here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169114174
DTIL 1.28: No brainer for real.
Just had new data supporting way to help others who had failed CAR-t therapy.
Got many upgrades in diary book of tabs.
Got a negative freak market perform downgrade.
This bio company actually has increasing revenue streams.
Yahoo book value 1.13.
90 million net cash.
But golden is my observation just confirmed in this post by this end point wizard whom I consider comfortably "renowned:"
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169113586
Congrads on your MICS hold, as my stereoscope was broken.
DTIL: thought DTIL had new CAR-T formula for the relapsed patients who previously failed, do I have it completely wrong?
https://www.biospace.com/article/releases/precision-biosciences-provides-update-on-allogeneic-car-t-programs-and-path-forward-with-its-lead-pbcar0191-candidate-for-car-t-relapsed-patient-population/
Congrads!!!!!!!!!!!!!!! 6.43!!!!!!!!!!!!!
MICS 2.39 to 6.43 yoyo mostly today.
MICS 6.43 low float "no brainer" which I did not fully swallow.
Should be buy-off with 1 % hike as inflation must be fried before it builds up steam or then just throw 956 billion to set off supply chain
gluts.
4.75 HOD on tank day, you holders are wizards!
BRN 2.70 restart.
DOLE 9.05 back "on the DOLE" depression era-wise..
DTIL: new lows $1.32 near Yahoo stat of $1.13 book value, what am I missing?
MICS move to 2's was warrant warfare, which was posted on that board but do not grasp.
BDCO halted as vol. less than 1K?
MICS sadly in same position as continuous victory dance in face of its heroic rises worth double in this market, is now a frightful sight for non-bag holders.
DOLE: confirms 8 cents divy and jumps .13 cents as new lows are defended while market tanks hard.
Thunderous inflation as experts (those in charge) are still getting it wrong, maybe by a mile. wonder if true not too late to chase oil stocks like a varmit?
DTIL 1.46 forced down on" punk" market perform downgrade.
MICS: 4.30 ,low float lane speeds things up!
DOLE: risk of much higher cost of revenue and dividend reduction, has been mixed bag for farmers.
BDCO nice bottom catch!
SPND 3.28 still like?
DTIL added 1.59 on "punk" downgrade to market perform.
DTIL 1.59 add on "punk" downgrade to market perform.
CURV: fear all the stuff you heard, plus massive pre-buys of most of their rough indoor relaxation casual "classics".
DTIL 1.81 added.
Always I am on the fence regarding drug Co's prices but never regarding the insidious middlemen, unless they are trying to adopt a Mark Cuban model (which seems in right direction?)..
Just noting:Target earmarking write offs on imperative inventory reductions, all shelf stuff not wearing preventative bullet proof vests.
thanks for reminder!
BRN 3.07waking up with rest of beasts.
DTIL why weak after strong report today?
MICS recovery with a stutter.
What think you: DTIL $2?
With eyes on first allogeneic CAR-T approval, Precision touts 100% response in 'small niche' population – Endpoints News (endpts.com)
https://endpts.com/with-eyes-on-first-allogeneic-car-t-approval-precision-touts-100-response-in-small-niche-population/?utm_medium=email&utm_campaign=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic&utm_content=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic+CID_6945d38e34406c0918c370e2a5f5ce01&utm_source=ENDPOINTS%20emails&utm_term=With%20eyes%20on%20first%20allogeneic%20CAR-T%20approval%20Precision%20touts%20100%20response%20in%20small%20niche%20population
What think you: DTIL $2?
With eyes on first allogeneic CAR-T approval, Precision touts 100% response in 'small niche' population – Endpoints News (endpts.com)
https://endpts.com/with-eyes-on-first-allogeneic-car-t-approval-precision-touts-100-response-in-small-niche-population/?utm_medium=email&utm_campaign=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic&utm_content=1486%20-%20As%20Moderna%20touts%20Omicron%20booster%20top%20analyst%20says%20MA%20will%20soon%20be%20needed%20Bristol%20Myers%20ups%20the%20ante%20in%20AI%20with%20new%20biotech%20partnership%20Basic+CID_6945d38e34406c0918c370e2a5f5ce01&utm_source=ENDPOINTS%20emails&utm_term=With%20eyes%20on%20first%20allogeneic%20CAR-T%20approval%20Precision%20touts%20100%20response%20in%20small%20niche%20population
HCDI 1.89 helping the home team today on delayed rise.